Breaking News, Collaborations & Alliances

Aurisco to Build Oligonucleotides Manufacturing Facility in China

Partners with Cytiva to build its first Oligo FlexFactory for commercial production.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Aurisco, a pharmaceutical company and contract development and manufacturing organization (CDMO) in China, is cooperating with global life sciences company Cytiva, to build its first Oligo FlexFactory platform for commercial production. The Oligo FlexFactory platform is the first of the three planned commercial manufacturing lines of Aurisco in Yangzhou of East China. The entire manufacturing site is expected to produce 200 kilograms of oligonucleotides every year. Oligonucleotides are syn...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters